Axon Enterprise, Inc $AXON Holdings Decreased by Artemis Investment Management LLP

Artemis Investment Management LLP trimmed its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 51.9% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 129,625 shares of the biotechnology company’s stock after selling 140,126 shares during the period. Artemis Investment Management LLP’s holdings in Axon Enterprise were worth $54,769,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently bought and sold shares of the business. Keating Financial Advisory Services Inc. purchased a new position in Axon Enterprise during the 2nd quarter valued at about $31,000. Washington Trust Advisors Inc. boosted its holdings in shares of Axon Enterprise by 1,300.0% during the second quarter. Washington Trust Advisors Inc. now owns 70 shares of the biotechnology company’s stock worth $39,000 after purchasing an additional 65 shares during the period. Wealth Enhancement Trust Services Inc. purchased a new position in Axon Enterprise during the third quarter valued at approximately $33,000. Delos Wealth Advisors LLC purchased a new position in Axon Enterprise during the second quarter valued at approximately $45,000. Finally, Owl Creek Wealth Partners LLC increased its stake in Axon Enterprise by 84.8% in the 2nd quarter. Owl Creek Wealth Partners LLC now owns 85 shares of the biotechnology company’s stock valued at $48,000 after buying an additional 39 shares during the period. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities research analysts have issued reports on AXON shares. The Goldman Sachs Group reissued a “buy” rating and set a $715.00 target price on shares of Axon Enterprise in a research note on Thursday, August 6th. Morgan Stanley increased their price objective on Axon Enterprise from $600.00 to $640.00 and gave the stock an “overweight” rating in a report on Thursday, August 6th. Argus boosted their target price on Axon Enterprise from $460.00 to $600.00 and gave the company a “buy” rating in a research note on Thursday, September 3rd. Royal Bank Of Canada reiterated an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, July 21st. Finally, Citizens Jmp reissued a “market outperform” rating and issued a $700.00 price target on shares of Axon Enterprise in a research note on Thursday, June 25th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $721.57.

Axon Enterprise Stock Performance

Shares of NASDAQ:AXON traded up $3.39 during midday trading on Thursday, hitting $409.39. The company’s stock had a trading volume of 399,147 shares, compared to its average volume of 1,050,204. The stock has a market capitalization of $33.26 billion, a price-to-earnings ratio of 170.30, a PEG ratio of 7.88 and a beta of 1.44. The stock’s 50 day simple moving average is $522.70 and its 200 day simple moving average is $477.18. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.80 and a current ratio of 2.15. Axon Enterprise, Inc has a fifty-two week low of $339.01 and a fifty-two week high of $764.02.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings results on Wednesday, August 5th. The biotechnology company reported $1.88 EPS for the quarter, topping analysts’ consensus estimates of $1.84 by $0.04. The company had revenue of $904.39 million during the quarter, compared to analyst estimates of $876.42 million. Axon Enterprise had a return on equity of 2.84% and a net margin of 6.19%.The company’s quarterly revenue was up 35.3% compared to the same quarter last year. During the same period in the previous year, the company earned $2.12 earnings per share. As a group, research analysts anticipate that Axon Enterprise, Inc will post 2.12 earnings per share for the current year.

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, insider Isaiah Fields sold 1,017 shares of the company’s stock in a transaction that occurred on Friday, September 11th. The stock was sold at an average price of $480.45, for a total value of $488,617.65. Following the completion of the transaction, the insider owned 56,264 shares of the company’s stock, valued at $27,032,038.80. This represents a 1.78% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Jeffrey Kunins sold 9,605 shares of the firm’s stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $626.70, for a total transaction of $6,019,453.50. Following the transaction, the insider directly owned 97,761 shares of the company’s stock, valued at $61,266,818.70. The trade was a 8.95% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 47,397 shares of company stock valued at $26,722,984 in the last ninety days. 4.20% of the stock is owned by corporate insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops technology and connected systems for public safety and law enforcement agencies. Its product portfolio includes TASER conducted energy weapons, body-worn cameras, in-car cameras and other recording devices designed to support safer interactions, improve accountability and document incidents.

The company also provides cloud-based software for managing digital evidence, reports, records and agency operations. Its Axon platform connects hardware with services such as evidence management, real-time operations, computer-aided dispatch and other workflow tools, enabling agencies to store, organize and share information across their organizations.

Founded in 1993 as AIR TASER by Rick Smith and Tom Smith, the company later operated as TASER International before adopting the name Axon Enterprise in 2017.